MARC details
000 -LEADER |
fixed length control field |
03621cam a2200517 i 4500 |
001 - CONTROL NUMBER |
control field |
ocn987051883 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20210921181123.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
ta |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
170321s20172017enka |rb 001|0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2017932606 |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
National bibliography number |
GBB755080 |
Source |
bnb |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
101710331 |
Source |
DNLM |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
018275949 |
Source |
Uk |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780198749691 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780198749691: |
Terms of availability |
£39.99 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0198749694 |
029 0# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
NLM |
System control number |
101710331 |
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
AU@ |
System control number |
000059983267 |
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
UKMGB |
System control number |
018275949 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)987051883 |
Canceled/invalid control number |
(OCoLC)980423226 |
-- |
(OCoLC)980723561 |
-- |
(OCoLC)981043372 |
-- |
(OCoLC)981145868 |
-- |
(OCoLC)981628619 |
-- |
(OCoLC)981780679 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
NLM |
Modifying agency |
UKUOY |
-- |
OCLCF |
-- |
YDX |
-- |
BDX |
-- |
EYM |
-- |
VMY |
-- |
SINLB |
-- |
NRC |
-- |
MOU |
-- |
ZLM |
-- |
OCLCO |
-- |
OCLCA |
-- |
U3W |
-- |
OCLCQ |
-- |
OCLCO |
-- |
UWW |
-- |
OCLCQ |
-- |
AU@ |
-- |
UKMGB |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Edition number |
23 |
Item number |
PAT |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Patrick, Graham L., |
Relator term |
author. |
245 13 - TITLE STATEMENT |
Title |
An introduction to medicinal chemistry / |
250 ## - EDITION STATEMENT |
Edition statement |
6th edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Oxford, United Kingdom : |
Name of producer, publisher, distributor, manufacturer |
Oxford University Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2017. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxxi, 877 pages : |
Other physical details |
illustrations |
Dimensions |
27 cm. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rdacontent |
336 ## - CONTENT TYPE |
Content type term |
still image |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes appendices, bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Drugs and drug targets : an overview -- Protein structure and function -- Enzymes : structure and function -- Receptors : structure and function -- Receptors and signal transduction -- Nucleic acids : structure and function -- Enzymes as drug targets -- Receptors as drug targets -- Nucleic acids as drug targets -- Miscellaneous drug targets -- Pharmacokinetics and related topics -- Case study 1 : statins -- Drug discovery : finding a lead -- Drug design : optimizing target interactions -- Drug design : optimizing access to the target -- Getting the drug to market -- Case study 2 : the design of ACE inhibitors -- Case study 3 : artemisinin and related antimalarial drugs -- Case study 4 : the design of oxamniquine -- Combinatorial and parallel synthesis -- Computers in medicinal chemistry -- Quantitative structure-activity relationships (QSAR) -- Case study 5 : design of a thymidylate synthase inhibitor -- Antibacterial agents -- Antiviral agents -- Anticancer agents -- Cholinergics, anticholinergics, and anticholinesterases -- Drugs acting on the adrenergic nervous system -- The opioid analgesics -- Anti-ulcer agents -- Cardiovascular drugs -- Case study 6 : steroidal anti-inflammatory agents -- Case study 7 : current research into antidepressant agents -- Case study 8 : the design and development of aliskiren -- Case study 9 : factor Xa inhibitors -- Case study 10 : reversible inhibitors of HCV NS3-4A protease -- Appendix 1 : essential amino acids -- Appendix 2 : the standard genetic code -- Appendix 3 : statistical data for QSAR -- Appendix 4 : the action of nerves -- Appendix 5 : microorganisms -- Appendix 6 : trade names and drugs -- Appendix 7 : hydrogen bonding interactions. |
520 8# - SUMMARY, ETC. |
Summary, etc. |
Providing an introduction to medicinal chemistry, this resource covers basic principles and background, and describes the general tactics and strategies involved in developing an effective drug. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical chemistry. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chemistry, Pharmaceutical. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Design. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacokinetics. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Standard Loan |
Suppress in OPAC |
0 |
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN) |
h (OCLC) |
NO HOLDINGS IN LQI - 88 OTHER HOLDINGS |